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Langerhans cells (LC) are a special subset of dendritic cells integrating cutaneous immunity. The study of LC
function is of major interest not only for efforts of vaccine design and immunotherapy but also for gaining an
insight into the pathogenesis of immune-mediated cutaneous diseases and neoplasias. Recently, deﬁned antigen-
presenting cells were described that express indoleamine 2,3-dioxygenase (IDO) and inhibit T cell proliferation
in vitro and in vivo. Here, we show that stimulation with interferon-c (IFN-c) induces the expression of functionally
active IDO in highly puriﬁed human epidermal LC. The induction of IDO after stimulation of LC with IFN-c seems to
follow a deﬁned kinetic with rapid upregulation followed by a downregulation after about 24 h of culture.
Accordingly, proliferation of T cells induced by anti-CD3 antibodies was modulated by supernatants of IFN-c-
activated human epidermal LC. Importantly, downregulation of T cell proliferation by supernatants of 24 h IFN-c-
activated LC was prevented by inhibition of IDO. These results indicate that LC not only have the capacity to
stimulate but also to inhibit T cells, and suggest that LC possess an immunoregulatory function in promoting T cell
tolerance by production of IDO.
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The development of an adaptive immune response requires
presentation of antigens to T cells by specialized cells.
Besides the mere presentation of MHC–peptide complexes,
the crucial role of antigen-presenting cells (APC) entails the
delivery of co-stimulatory signals to T cells. Co-stimulatory
signals can be either provided by membrane-bound ligands
or by soluble factors secreted by APC, and the sum of these
signals will determine the outcome of the T cell response,
ranging from a productive response to T cell unresponsive-
ness (Guermonprez et al, 2002; Lutz and Schuler, 2002). It is
now clear that dendritic cells (DC) are the most important
APC (Steinman, 2003). DC are found in lymphatic and some
non-lymphatic tissues, and various subgroups of DC have
been recognized based, for instance, on surface molecule
expression, their varying capacity to secrete cytokines, or
their responsiveness to microbial ligands such as CpG-DNA
(Kaisho and Akira, 2003). Besides their well-established
function in picking up antigens and initiating an adaptive
immune response, recent evidence indicates that DC may
also respond to complex information from sites of chronic
infections, such as autoimmune disorders, and may be able
to downregulate an immune response (Zhang et al, 2003).
One way in which how such a regulatory signal can be
delivered is the expression of the tryptophan-catabolizing
enzyme indoleamine 2,3-dioxygenase (IDO) (Grohmann
et al, 2003; Mellor et al, 2003). IDO activity results in
tryptophan depletion and the accumulation of its metabo-
lites in the extracellular space (Terness et al, 2002). The
expression of IDO by various cells has been demonstrated
to block T cell responses in a number of situations, such as
immune tolerance toward allogeneic fetuses (Munn et al,
1998), the inhibition of graft rejection (Grohmann et al,
2002), or, possibly, the prevention of allergic disease in
some individuals (von Bubnoff et al, 2002). A recent study
shows that a subset of monocyte-derived human DC
(defined by the expression of CD123 and CCR6) constitu-
tively expresses IDO (Munn et al, 2002). Furthermore, IDO
expression by DC has been shown to have consequences
for the development of an immune response in vivo.
Injection of the immunomodulatory reagent CTLA4-Ig into
mice induced IDO expression in specific DC subsets of the
spleen and prevented the development of a specific CD8 T
cell response (Mellor et al, 2003). Therefore, specialized DC
subsets appear to exist, which can, by virtue of their
capacity to produce IDO, negatively affect a T cell response.
This is probably due to the induction of apoptosis as a
consequence of tryptophan depletion and/or metabolite
accumulation (Fallarino et al, 2002).
Langerhans cells (LC) are a subset of DC that are
typically localized in the basal and suprabasal layers of the
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epidermis and along mucosal surfaces (Allam et al, 2003). In
the healthy skin, immature LC reside in a ‘‘steady state’’ for
a number of months without recycling and have been
regarded as sentinels of the immune system (Merad et al,
2002). The traditional view is that LC, in response to danger
signals, capture, process, and present antigens. According
to this model, upon microbial contact, LC undergo matura-
tion and migrate from the epidermis to regional lymph
nodes where they stimulate T cells (Stingl et al, 1980). This
scenario has experimental support from data obtained in
the study of contact allergic reactions, where contact-
sensitizing agents can be visualized in LC of lymph nodes
(Krasteva et al, 1996; Wang et al, 2002). In addition, LC play
a critical role in the pathogenesis of atopic dermatitis
(Bieber, 1995; Reich et al, 2002). In this condition, LC are
activated by immune complexes of allergens and specific
IgE that bind to the high-affinity receptor for IgE, FceRI, on
LC (Jurgens et al, 1995; Kraft et al, 2002). These LC are able
to present foreign antigens in vitro and probably interact
with T cells in vivo (Mudde et al, 1990).
Two recent studies challenge this long-held opinion of LC
function by the demonstration that LC do not play a leading
role in activating T cell-mediated defenses against viral
infections of the skin or mucosa (Allan et al, 2003; Zhao
et al, 2003). Since the main role of LC as being primary
stimulators of T cells has thus been contested, we reasoned
that LC might possess regulatory, i.e., inhibitory, functions.
Therefore, we investigated the potential of human epidermal
LC to express functional IDO and to suppress T cell
responses.
Results
Detection of IDO transcripts in highly puriﬁed human
epidermal LC and keratinocytes (KC) Highly purified
human epidermal LC and KC were investigated for IDO
transcripts. The cells were cultured for 24 h in the presence
or absence of interferon-g (IFN-g). Semiquantitative analysis
of transcripts for IDO was performed by PCR. The density of
the b-actin PCR band on the gel was used as internal
standardization for equal cDNA loading. Transcripts for IDO
could be clearly detected in unstimulated LC (Fig 1A). In
IFN-g-stimulated LC, PCR for IDO gave a strong signal. In
24 h cultured unstimulated KC, a faint band after PCR for
IDO was present. IDO mRNA was clearly detectable when
cells had been IFN-g stimulated, but the level of IDO
transcripts appeared weaker than with LC (Fig 1B). Signi-
ficant contamination of KC with LC is unlikely since specific
fragments for Langerin, an LC-specific cell protein, could
not be amplified after 27 cycles, whereas under the same
conditions, RT-PCR using RNA from LC gave maximal ampli-
fication products (data not shown). Together, these results
demonstrate that in human epidermal LC and KC, IDO
mRNA expression is induced after stimulation with IFN-g.
Intracellular protein expression of IDO in isolated
human epidermal cells To detect IDO protein expression,
immunofluorescence staining was performed on freshly
isolated and on 24 h cultured epidermal cells either
stimulated with IFN-g or not. Immunolabeling was per-
formed with anti-IDO monoclonal antibodies (mAb), anti-
CD1a mAb, and the respective isotype controls. In freshly
isolated epidermal cells after density centrifugation (15%–
30% LC), IDO protein expression was not detected in LC
and in KC (Fig 2A). After stimulation of highly purified LC for
24 h with IFN-g, IDO protein expression could be clearly
found in all cells, and some LC displayed a very strong
staining (Fig 2B). IDO protein expression could also be
detected in about 20%–50% of 24 h cultured unstimulated,
highly purified CD1aþ cells, but the intensity of the staining
was weaker than with stimulated cells. Highly purified, 24 h
cultured unstimulated KC did not show IDO protein
expression, whereas in 24 h IFN-g-stimulated KC, a weak
expression of IDO protein could be seen (Fig 2C). The same
pattern of IDO protein expression in 24 h cultured
stimulated and unstimulated LC and KC was observed
after density centrifugation (data not shown). Together,
these results demonstrate strong IDO protein expression in
24 h IFN-g-activated, human epidermal LC, and a weak IDO
expression in some unstimulated cultured LC and IFN-g-
stimulated KC. Freshly isolated LC and KC and unstimu-
lated 24 h cultured KC do not seem to express IDO protein.
Induction of functionally active IDO in human isolated
epidermal LC after stimulation with IFN-c The next
question we addressed was whether IFN-g-induced IDO
was functionally active in LC, i.e., capable of degrading
tryptophan. Therefore, IDO activity was measured as the
level of tryptophan consumed and kynurenine generated in
the culture supernatants, a well-defined system of IDO
activity (von Bubnoff et al, 2002). Highly purified LC were
stimulated or not in increasing cell numbers with IFN-g
(50 ng per mL) for 24 h in tryptophan-free medium
supplemented with 100 mM tryptophan (Fig 3). Supernatants
were harvested and the degradation of tryptophan and the
presence of kynurenine were analyzed by high-performance
liquid chromatography (HPLC). In unstimulated, 24 h
cultured LC, no significant functional IDO activity could be
detected. Interestingly, in 24 h IFN-g-stimulated LC,
significant IDO activity could only be observed at high cell
numbers, i.e., with 1.5  106 cells per mL, as revealed by
the concomitant degradation of tryptophan and production
of kynurenine. In unstimulated and IFN-g-stimulated CD1a
KC, no degradation of tryptophan and no increase in
Figure 1
Interferon-c (IFN-c) induces indoleamine 2,3-dioxygenase (IDO)
mRNA in epidermal Langerhans cells (LC) and keratinocytes (KC).
RT-PCR showing IDO expression in 24 h cultured unstimulated (+) and
IFN-g-stimulated (50 ng per mL, # ) (A) highly purified LC and (B)
CD1a KC.
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kynurenine was observed throughout the range of increas-
ing cell numbers up to 1.5  106 per mL (data not shown).
These results demonstrate that IFN-g stimulation induces
the expression of functionally active IDO in human
epidermal LC.
Kinetics of IDO activity in isolated human epidermal LC
and monocytes To determine the amount of tryptophan
degradation and kynurenine production in normal medium
over time, cultures of highly enriched IFN-g-activated and
non-activated LC and, for comparison, of monocytes, were
investigated for functional IDO after 24 and 48 h of culture
(Fig 4). Supernatants were harvested after the first 24 h of
incubation, the cells were washed once, and incubated for
an additional 24 h in the absence of IFN-g. Interestingly, IDO
activity was strongly induced in LC during the first 24 h of
IFN-g stimulation, but was markedly decreased thereafter.
In monocytes, IDO activity followed a different time course.
Although only moderate IDO activity was induced during the
first 24 h of culture, a marked increase in IDO activity was
seen during the second 24 h of incubation. The viability and
cell numbers of LC and monocytes did not decrease
significantly as confirmed by trypan blue exclusion at 48 h
of culture. These results suggest that in human epidermal
Figure 2
Intracellular expression of indoleamine 2,3-dioxygenase (IDO)
protein in epidermal Langerhans cells (LC) (CD1aþ ) and keratino-
cytes (KC) (CD1a). (A) Freshly isolated epidermal cells after density
centrifugation (15%–30% LC), (B) 24 h cultured unstimulated and
interferon-g (IFN-g)-stimulated highly enriched CD1aþ LC and (C)
highly enriched 24 h cultured unstimulated and IFN-g-stimulated KC
were allowed to adhere to coverslips, fixed, and permeabilized using
0.05% saponin. Cells were double labeled with anti-CD1a-FITC and
anti-IDO (revealed by Cy3-conjugated goat-anti-mouse IgG).
Figure3
Induction of functionally active indoleamine 2,3-dioxygenase in
human epidermal Langerhans cells (LC). Highly enriched LC were
incubated at increasing cell numbers (120  104cells per 100 mL,
150  104 cells per mL) in tryptophan-free medium supplemented with
100 mM tryptophan. Cells were stimulated with interferon-g (’) or not
(&) for 24 h. Supernatants were collected and analyzed for tryptophan
and kynurenine by high-performance liquid chromatography.
Figure4
Kinetics of tryptophan catabolism and kynurenine production by
Langerhans cells (LC) and monocytes. Highly purified LC and
monocytes (each 1  106 per mL) were stimulated with interferon-g
(’) or not (&) for 24 h in normal culture medium. The medium was then
replaced and the cells incubated for another 24 h. Tryptophan and
kynurenine levels were measured after 24 and 48 h of culture by high-
performance liquid chromatography. Representative data are shown
from one of three independent experiments.
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LC, the upregulation of IDO by IFN-g is only transient,
followed by a rapid decline in activity. Another possibility is
that LC need, in contrast to monocytes, sustained stimula-
tion with IFN-g to maintain IDO activity.
Both inhibitory and stimulatory properties toward T
cells are found in supernatants of IFN-c-activated
human isolated epidermal LC The stimulatory capacity
of APC toward T cells depends on the expression of surface
molecules and the secretion of soluble factors. The
accessory function of freshly isolated LC is weak, but
increases dramatically during culture for 48 h (Picut et al,
1988). We addressed the question of what the effect of
IFN-g-induced IDO activity was on the overall stimulatory
activity of LC-derived supernatants. First, supernatants
from LC cultures were tested in a time course experiment
for their effect on supporting T cell proliferation. Highly
enriched human LC were stimulated for 48 h with IFN-g or
not at a cell concentration of 1  106cells per mL. Super-
natants were collected after 24, 36, and 48 h and tested for
their effect on CD3-driven T cell proliferation (Fig 5).
Importantly, compared with T cell proliferation in super-
natants from unstimulated LC, T cell proliferation was
markedly reduced in supernatants from 24 h- and 36 h-
IFN-g-stimulated LC. In contrast, by 48 h of culture,
supernatants from IFN-g-stimulated LC showed increased
stimulatory capacity toward T cells compared with super-
natants from unstimulated LC. These results suggest that
LC exert activation-dependent dual contributions, i.e.,
suppressive and immunogenic functions to T cells after
activation with IFN-g.
The stronger inhibitory activity in supernatants from
24 h IFN-c-stimulated LC is due to IDO activity The lower
proliferation of T cells stimulated in the presence of
supernatants from IFN-g-treated LC compared with un-
treated LC correlated in time with the detected IDO activity.
Therefore, we tested whether IDO activity was responsible
for this ‘‘suppression’’. LC were left unstimulated, or were
stimulated with IFN-g in normal culture medium and in
culture medium substituted with the IDO-inhibitor 1-methyl-
tryptophan (1-MT) for 24 h. Supernatants were collected
and induction of T cell proliferation by surface-bound anti-
CD3 mAb in these supernatants was determined (Fig 6). As
before, T cell proliferation in supernatants from 24 h IFN-g-
stimulated LC was reduced compared with T cell prolifera-
tion in supernatants from unstimulated cells. Interestingly,
this reduction in T cell proliferation was completely
prevented in two independent experiments and partially
prevented in one experiment (data not shown) when
supernatants from LC were used, whose activation had
been performed in the presence of 1000 mM 1-MT. Together,
these results identify LC-derived IDO activity as a T cell
inhibitory factor.
Discussion
In this study, we show that highly purified human epidermal
CD1aþ LC have the potential to express IDO in response to
stimulation with IFN-g. Although it is known that epidermal
KC exert considerable stimulatory and regulatory functions
on LC (Cumberbatch et al, 1997), IDO induction in human
epidermal LC seems to be independent of KC. Using a
method that combines the techniques of density centrifuga-
tion and immunomagnetic bead isolation, highly purified
CD1aþ LC (490%) were obtained. In this cell fraction, and
not in the CD1a fraction of KC, functional IDO-protein ex-
pression was greatly enhanced after stimulation with IFN-g.
The functional activities of DC largely depend on their
state of activation and differentiation. In particular, freshly
isolated LC are relatively poor T cell stimulators but gain
high stimulatory capacity after about 48 h of culture (Schuler
and Steinman, 1985). Unlike mature DC, immature DC may
have functions to induce and maintain T cell tolerance in the
periphery (Steinman et al, 2003). How this maintenance
could be achieved on a cellular or molecular level is
uncertain. Our study suggests that the induction of IDO
may play a key role in silencing T cell responses by
immature LC. High IDO activity after IFN-g stimulation of LC
was short-lived and was seen only during the first 24 h of
culture. This suggests that after IFN-g stimulation, rapid
induction of IDO may be abrogated by factors that promote
LC maturation and IDO downregulation. LC maturation has
been characterized mostly in vitro and can be induced by
proinflammatory cytokines and/or the increase of defined
costimulatory molecules (Symington et al, 1993; Wang et al,
Figure 5
Tcell inhibiting and stimulating activities in supernatants from interferon-c (IFN-c)-activated Langerhans cells (LC). LC (1  106 per mL) were
activated with IFN-g (’) or not (&) for a total of 48 h. After 24, 36, and 48 h supernatants were collected and T cells (2  105) were stimulated in
these supernatants by surface-bound anti-CD3 monoclonal antibodies (10 mg per mL, 100 mL per well). Seventy-two hours later, T cell proliferation
was measured. As control, T cells were stimulated in normal culture medium (CM). Three independent experiments are shown.
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1999). To correlate IDO-dependent regulatory functions to
LC maturation, we compared the expression of CD83, HLA-
DR, and CD86 on freshly isolated LC with the expression on
LC after 48 h of culture by FACS analysis (data not shown).
Whereas only about 25% of freshly isolated LC expressed
the maturation marker CD83, all LC stained positive for
CD83 after 48 h of culture. In addition, compared with
freshly isolated LC, the costimulatory molecule CD86 was
strongly increased on 48 h cultured, IFN-g-stimulated, and
unstimulated LC. MHC class II was slightly decreased on
the cell surface of unstimulated LC after 48 h but was
preserved at high expression levels on IFN-g-stimulated
cells. It was difficult to quantify the difference of IDO protein
expression between 24 and 48 h IFN-g-stimulated LC by
immunofluorescence because cells at 48 h had a comple-
tely different cell shape as a reflection of their maturity.
Nevertheless, IDO protein expression appeared to be
markedly weaker, although not completely downregulated,
in mature IFN-g-stimulated LC by immunofluorescence
(data not shown). Together, these experiments do not rule
out the possibility that functional IDO activity is even
sustained in mature LC under defined circumstances.
Functionally, supernatants from short-term-cultured and
stimulated LC, but not from longer cultures, had suppres-
sive effects on T cell proliferation. In this context, we could
demonstrate that increased IDO activity was the main
suppressive mediator of T cell proliferation in these super-
natants since the IDO-inhibitor 1-MT prevented T cell
suppression in supernatants from 24 h IFN-g-activated
LC. These data clearly show that activated immature LC
have the potential to affect T cell responses negatively. The
kinetics suggest that the observed immunosuppressive
effect of IFN-g-stimulated LC-culture supernatants results
from short-lived products derived from the tryptophan
degradation pathway and not from tryptophan deprivation
itself. In this regard, it is well known that the metabolic
product 3-hydroxykynurenine is very unstable in the culture
medium and it can be toxic to various cells (Okuda et al,
1996). Our observations in LC parallel the findings from
other studies with CD123þCCR6þ IDOþDC, where IFN-g-
induced functional IDO in immature DC, but completely
downregulates the enzymatic activity of IDO in mature DC
(Munn et al, 2002). There, the expression of functional IDO
in mature DC was sustained in the presence of the
regulatory cytokines interleukin-10 or transforming growth
factor-b.
Our data clearly show that LC can express both
stimulatory and inhibitory (i.e., IDO) activities. The extent
to which IDO expression by LC impacts on the balance
between tolerance and immunity in vivo remains to be
determined. T cell proliferation may be inhibited or
regulatory T cells may be activated by the degradation of
tryptophan/increase of metabolites. Now that recent evi-
dence disputes that LC are the initiators of the immune
response upon microbial infection, the maintenance of
tolerance in certain situations is a possible function for
these cells that will have to be further explored.
Materials and Methods
Reagents FITC- or PE-labeled mAb to human CD1a, CD14, HLA-
DR, CD83, CD86, and isotype controls were used to stain LC and
monocytes for immunofluorescence and FACS procedures (Phar-
mingen, San Diego, California). An mAb against human IDO
(mouse IgG1) was provided by Takikawa et al (1988). Cy3-labeled
IgG goat-anti-mouse Ab was purchased from Beckman Coulter
(Paris, France). Poly-L-lysine, DNAse, trypsine, saponin (S-7900),
and tryptophan were purchased from Sigma (St Louis, Missouri).
IFN-g was used to activate LC, monocytes, and KC (R&D,
Wiesbaden, Germany). RPMI-VLE (very low endotoxin) 1640
medium, tryptophan-free RPMI-VLE 1640 medium and trypto-
phan-free fetal calf serum (FCS) were purchased from Biochrom
(Berlin, Germany). Normal FCS, L-glutamine, antibiotics/antimyco-
tics were from Invitrogen (Karlsruhe, Germany).
Isolation of epidermal cells and enrichment for LC Normal
human split skin was obtained from patients undergoing abdominal
plastic surgery, as previously described (Bieber et al, 1992). Written
informed consent was obtained from all patients and the protocol
was approved by the local ethic committe. Cell suspensions were
prepared as described (Hanau et al, 1987). These suspensions
contained 0.5%–2% freshly isolated CD1aþ LC and were enriched
for LC by density gradient centrifugation on ficoll (Lymphocyte
separation medium, Eurobio, Les Ullis, France). The interface
(15%–30% LC) was collected, washed, and subjected to further
positive immunomagnetic isolation with Miltenyi beads (Miltenyi
Biotec, Bergisch Gladbach, Germany). Then, the cells were
separated into CD1aþ LC and CD1a KC with a Positive Selection
MS Column (Miltenyi Biotec) according to the manufacturer’s
instructions. The enrichment for LC (490%) was controlled by
CD1a immunolabeling.
Figure 6
Reduced Tcell proliferation in supernatants from interferon-c (IFN-
c)-activated Langerhans cells (LC) is due to enhanced indoleamine
2,3-dioxygenase (IDO) activity. Highly purified human LC (1  106 per
condition) were left unstimulated or were activated with IFN-g in the
absence and in the presence of the IDO inhibitor 1-methyltryptophan
(1-MT) (1000 mM). After 24 h of culture, supernatants were collected
and T cells were stimulated in these supernatants by surface-bound
anti-CD3 monoclonal antibodies (10 mg per mL, 100 mL per well). (&)
Supernatants of unstimulated LC; (’) supernatants of 24 h IFN-g-
activated LC; ( ) supernatants of LC that had been IFN-g-activated for
24 h in the presence of 1-MT (1000 mM). Representative data
(mean  SD) are shown from one of three independent experiments
done in triplicate.
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Isolation of monocytes Peripheral blood monocytes were iso-
lated as described (von Bubnoff et al, 2003). CD14 expression was
determined by flow cytometry and was 490% of isolated cells.
Flow cytometric analysis of LC For quantitative evaluation of
surface antigens, dead cells were excluded by 7-amino-actinomy-
cin D staining, and the CD1aþ population was gated out manually.
Stimulation of LC and monocytes Epidermal cell suspensions
after density centrifugation (15%–30% LC), highly enriched LC,
and monocytes (both 490% purity) were stimulated or not for 24 h
with IFN-g (50 ng per mL) in 14 mL polypropylene round-bottom
Falcon tubes (BD Biosciences, Heidelberg, Germany) at the
indicated densities. As control cells, unstimulated cells were
incubated for the same time.
KC cultures The CD1a KC fraction was stimulated or not for 24 h
with IFN-g (50 ng per mL) in six-well plates (Nalge Nunc Inter-
national, Roskilde, Denmark) at a density of 1  106 cells per mL.
Cells were cultured in KC-SFM (serum-free medium) supplemen-
ted with bovine pituitary extract (20 mg per mL) and recombinant
epidermal growth factor (0.2 ng per mL; all from Invitrogen, Cergy-
Pontoise, France). The KC were recovered by a cell scraper for
subsequent isolation of RNA and immunofluorescence studies.
The supernatants were harvested for HPLC analysis of tryptophan
and kynurenine.
RT-PCR RT-PCR reactions were carried out as described (von
Bubnoff et al, 2002). Specific primer sequences for the genes were
as follows: human b-actin: forward 50-GAGCGGGAAATCGT GCGT-
GACATT-30 and reverse 50-GATGGAGTTGAAGGTAGTTTCGTG-30
(240 bp); human IDO: forward 50-CTTCCTGGTCTCTCTATTGG-30
and reverse 50-GAAGTTCCTG TGAGCTGGTG-30 (430 bp). The
PCR cycle number for the detection of IDO and Langerin was 27
and 25 for b-actin.
Immunoﬂuorescence staining of isolated LC and KC Immuno-
fluorescence microscopy of fixed permeabilized highly purified LC
(490% CD1aþ LC) and KC, or epidermal cells (LC and KC) after
density centrifugation (about 15%–30% LC), was carried out as
previously described (Saudrais et al, 1998). The concentration for
unconjugated anti-IDO mAb was 2.5 mg per mL, for the secondary
Ab goat-anti-mouse-Cy3 1/1200, and for anti-human-CD1a-FITC-
labeled Ab 2.5 mg per mL. Immunofluorescence analysis was
performed using a Leica DMR microscope (Microsystems, Heidel-
berg, Germany) interfaced with a 12V100W halogen lamp (Osram,
Munich, Germany). Double fluorescence acquisition was per-
formed using a  63 oil immersion Plan Apo objective (Merck,
Darmstadt, Germany) (numerical aperture¼ 1).
Kynurenine assay For HPLC analyses of tryptophan and kynur-
enine in cell supernatants with increasing amounts of LC numbers,
cells were incubated for 24 h in tryptophan-free medium
supplemented with 100 mM tryptophan. KC were cultured for 24 h
in KC-specific medium as described above. For kinetic studies,
cells were incubated in normal culture medium and either
stimulated or not. The baseline concentration of tryptophan in
normal culture medium was determined by HPLC and was
relatively constant over time (20–21 mM). Supernatants were
collected after 24 h of culture and cells were further incubated
with fresh medium for another 24 h without addition of further
IFN-g. Tryptophan and kynurenine levels were quantified by HPLC
from the first 24 h of incubation and after 48 h (¼ second 24 h) of
culture.
High-performance liquid chromatography Samples for the
determination of L-tryptophan and L-kynurenine were prepared
and assayed as described (von Bubnoff et al, 2002).
T cell proliferation assays T cell isolations from peripheral blood
of donors were carried out as described (von Bubnoff et al, 2002).
Allogeneic T cell proliferation assays were carried out as follows.
Highly purified LC (490% CD1aþ ) were isolated from human skin
as described above. Freshly isolated LC were added in increasing
cell numbers (from 0 to 10,000 cells) to 2  105 pure allogeneic T
cells. Cocultures were either stimulated with IFN-g (50 ng per mL)
or not. Seventy-two hours later, T cell proliferation was measured
using overnight incubation with [3H]thymidine (0.5 mCi per well).
To study T cell proliferation in supernatants of LC, an anti-CD3
mAb (R&D) was immobilized onto 96-flat bottom tissue culture
wells (1 mg per 100 mL per well) according to the manufacturer’s
protocol. T cells (1  105) were resuspended in 100 mL of
supernatant and seeded onto anti-CD3 mAb-coated wells. After
72 h, T cell proliferation was measured using overnight incubation
with [3H]thymidine (0.5 mCi per well).
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